Trial Profile
Evaluating relation between High Plasma Dabigatran Concentration Activated Partial Thromboplastin Time to Identify Patients at High Risk For Major Bleeding During Dabigatran
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Deep vein thrombosis; Embolism; Stroke
- Focus Pharmacodynamics
- 10 Dec 2015 New trial record